• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Lee Millard, England

    Lee Millard, England

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Olga, Argentina

    Olga, Argentina

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • JP

    JP

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Purningam Jacob, India

    Purningam Jacob, India

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Daniel Hare, USA

    Daniel Hare, USA

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Jean

    Jean
    jean

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Liam Dwyer, England

    Liam Dwyer, England

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Animesh Kumar, India

    Animesh Kumar, India

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Steve

    Steve

  • John Russo, USA

    John Russo, USA
    final3878

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login